CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −4,321 | $55.05 | $238K | 38,059 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise 10b5-1 | +371 | $33.02 | $12K | 38,430 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −351 | $55.09 | $19K | 38,079 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −20 | $55.64 | $1K | 38,059 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,321 | $33.02 | $143K | 0 |
| 2023-04-21 | Utter Christine Marie SVP, FINANCE & CAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −371 | $33.02 | $12K | 0 |
| 2023-04-21 | Reeve Emma Director | Sale 10b5-1 | −4,228 | $55.04 | $233K | 7,300 |
| 2023-04-21 | Reeve Emma Director | Sale 10b5-1 | −100 | $55.57 | $6K | 7,200 |
| 2023-04-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −732 | $52.04 | $38K | 64,805 |
| 2023-04-18 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +26,000 | 103,856 | ||
| 2023-04-18 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,211 | $52.04 | $63K | 102,645 |
| 2023-04-18 | Klein Matthew B. CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) 10b5-1 | +65,000 | 65,000 | ||
| 2023-04-17 | SOUTHWELL DAVID P Director | Option exercise 10b5-1 | +11,429 | $18.01 | $206K | 21,929 |
| 2023-04-17 | SOUTHWELL DAVID P Director | Sale 10b5-1 | −6,241 | $50.69 | $316K | 15,688 |
| 2023-04-17 | SOUTHWELL DAVID P Director | Sale 10b5-1 | −5,188 | $51.43 | $267K | 10,500 |
| 2023-04-17 | SOUTHWELL DAVID P Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,429 | $18.01 | $206K | 0 |
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +3,292 | $30.86 | $102K | 78,670 |
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −3,292 | $51.42 | $169K | 75,378 |
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +58,631 | $30.86 | $1.8M | 134,009 |
| 2023-04-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −58,631 | $51.42 | $3.0M | 75,378 |
Page 39 of 41 · 804 trades